Budesonide in Patients With Immune Mediated Enteropathies

NCT03866538 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study recruitment was difficult and not acheived

Conditions

Enteropathy
Celiac Disease
CVID Enteropathy
Collagenous Sprue
Autoimmune Enteropathy

Interventions

DRUG: Withdrawal of Oral Budesonide

Sponsor

Mayo Clinic